This report was recently updated on November 15 2024 with the latest and most recent
market numbers
Global Embolic Protection Devices Market Size, Trends & Analysis - Forecasts to 2029 By Product (Distal Occlusion Filters, Proximal Occlusion Filters, and Distal Filters), By Application (Neurovascular Diseases, Cardiovascular Diseases, and Peripheral Vascular Diseases), and By Region (North America, Asia Pacific Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global embolic protection devices market is projected to grow at a CAGR of 9.4% from 2024 to 2029.
Embolic protection devices are mainly used for cardiovascular interventions, particularly in procedures such as angioplasty and stenting. Factors such as rising neurovascular surgeries and increasing incidence of cardiovascular diseases are fuelling the market growth. Additionally increasing substantial investments in the research and development of embolic devices, are other key drivers fuelling the growth of the market.
According to WHO cardiovascular diseases are the main cause of deaths globally. It is estimated that over 17.9 million deaths are recorded each year. The increasing incidence of cardiovascular diseases, including coronary artery disease and peripheral artery disease, has played a crucial role in driving the adoption of embolic protection devices. Globally cardiovascular disease has increased from 12.4 million in 1990 to 19.8 million in 2022.
Furthermore, the increasing geriatric population is also contributing to the expansion of the market. As the older population grows, so does the demand for cardiovascular therapies and related devices, such as embolic protection devices. According to the World Health Organization by 2030 1 in 6 people will be aged 60 years or over.
Technological advancements and the launch of new products are anticipated to drive market growth. Device design, materials, and deployment techniques have improved in safety and efficacy, contributing to the market expansion. For example, in July 2020, Keystone Heart, a medical device innovator under Venus Medtech, announced the successful completion of the first worldwide commercial case using the TriGUARD 3 Cerebral Embolic Protection (CEP) Device.
The cardiovascular diseases segment is expected to hold the largest share of the market due to a significant rise in the number of cardiovascular diseases during the forecast year. According to the World Heart Federation 2023 report there is a 60% increase in global deaths from cardiovascular diseases (CVDs), the primary cause of fatalities worldwide. The numbers surged from 12.1 million in 1990 to 20.5 million in 2021.
The peripheral vascular diseases segment is expected to be the fastest-growing segment in the market from 2024-2029, owing to the rising aging population. As this disease mostly occurs in the population above the age of 60 years. According to WHO Report 2022, the aging population over 60 years from 2015 to 2050 will rise with double the number from 12% to 22%.
Distal occlusion filters segment is expected to hold the largest share of the market and is also expected to be the fastest-growing segment in the market from 2024-2029. The anticipated growth is due to its advantages such as user-friendly design and versatility in diverse medical conditions. Factors such as increasing neurovascular surgeries, rising obesity rates, and spinal cord injuries contribute to market expansion. World Health Organization (WHO) estimated in 2022 that approximately 167 million people will become less healthy as they will be overweight or obese, more than 1 billion people in the world are obese of which 650 million are adults, 39 million are children, and 340 million are adolescents. These factors are contributing to the increasing demand for the distal occlusion filters.
North America is expected to be the largest region in the market. The key reasons boosting the market growth in this region include the rising number of cardiovascular and high prevalence of neurovascular diseases. The region is known for its fast adoption of innovative and advanced technologies in the healthcare sector, with substantial funding for heart diseases. According to the Canadian Institution for Health Information, heart disease is the second leading cause of death in Canada and in July 2022 it was reported that 2.4 million Canadians have heart disease.
Asia Pacific is predicted to witness rapid growth during the forecast period. The aging population in Asia Pacific region is expanding, which is leading to increasing occurrence of age-related conditions, which also include cardiovascular diseases. According to the Economic and Social Commission for Asia and the Pacific, aging is occurring at a faster rate in the Asia Pacific region compared to other parts of the world. As of 2020, 13.6% of the population in Asia and the Pacific was 60 years old or older. Other factors such as increasing cardiovascular diseases, and increasing health care expenditures are also contributing to the growth of the embolic protection devices market in Asia Pacific region.
Boston Scientific Corp., Edward Lifesciences, Abbott Laboratories, Medtronic Plc, Cardinal Health, Claret Medical, Inc., Innovative Cardiovascular Solutions, LLC, Transverse Medical, Inc., Claret Medical, Inc., and Gore Medical, among others, are some of the key players operating in the global embolic protection devices market.
Please note: This is not an exhaustive list of companies profiled in the report.
In January 2023, Cardinal Health, a company specializing in healthcare services and products, has entered into a strategic collaboration with Palantir Technologies, known for building operating systems for the modern enterprise. The primary goal is to design a solution that gives health systems and hospitals dynamic purchase decision insights. The integrated solution will leverage artificial intelligence (AI) and machine learning (ML) technologies. These technologies will be employed to bring together diagnosis and clinical data with real-time customer purchasing and consumption data for pharmaceutical products.
In March 2021, Innovative Cardiovascular Solutions (ICS) announced the success of its first European clinical cases using the next generation of the EMBLOK Embolic Protection System. The EMBLOK Embolic Protection System is designed to address the risk of embolic debris liberated during transcatheter aortic valve replacement (TAVR) procedures.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 GLOBAL MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION
4.1 Introduction
4.2 Embolic Protection Devices Market: Application Scope Key Takeaways
4.3 Revenue Growth Analysis, 2023 & 2029
4.4 Neurovascular Diseases
4.4.1 Neurovascular Diseases Market Estimates and Forecast, 2021-2029 (USD Million)
4.5 Cardiovascular Diseases
4.5.1 Cardiovascular Diseases Market Estimates and Forecast, 2021-2029 (USD Million)
4.6 Peripheral Vascular Diseases
4.6.1 Peripheral Vascular Diseases Market Estimates and Forecast, 2021-2029 (USD Million)
5 GLOBAL EMBOLIC PROTECTION DEVICES MARKET, BY PRODUCT
5.1 Introduction
5.2 Embolic Protection Devices Market: Product Scope Key Takeaways
5.3 Revenue Growth Analysis, 2023 & 2029
5.4 Distal Occlusion Filters
5.4.1 Distal Occlusion Filters Market Estimates and Forecast, 2021-2029 (USD Million)
5.5 Proximal Occlusion Filters
5.5.1 Proximal Occlusion Filters Market Estimates and Forecast, 2021-2029 (USD Million)
5.6 Distal Filters
5.6.1 Distal Filters Market Estimates and Forecast, 2021-2029 (USD Million)
6 GLOBAL EMBOLIC PROTECTION DEVICES MARKET, BY REGION
6.1 Introduction
6.2 North America Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.1 By Application
6.2.2 By Product
6.2.3 By Country
6.2.3.1 U.S. Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.1.1 By Application
6.2.3.1.2 By Product
6.2.3.2 Canada Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.2.1 By Application
6.2.3.2.2 By Product
6.2.3.3 Mexico Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.3.1 By Application
6.2.3.3.2 By Product
6.3 Europe Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.1 By Application
6.3.2 By Product
6.3.3 By Country
6.3.3.1 Germany Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.1.1 By Application
6.3.3.1.2 By Product
6.3.3.2 U.K. Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.2.1 By Application
6.3.3.2.2 By Product
6.3.3.3 France Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.3.1 By Application
6.3.3.3.2 By Product
6.3.3.4 Italy Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.4.1 By Application
6.3.3.4.2 By Product
6.3.3.5 Spain Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.5.1 By Application
6.3.3.5.2 By Product
6.3.3.6 Netherlands Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.6.1 By Application
6.3.3.6.2 By Product
6.3.3.7 Rest of Europe Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.6.1 By Application
6.3.3.6.2 By Product
6.4 Asia Pacific Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.1 By Application
6.4.2 By Product
6.4.3 By Country
6.4.3.1 China Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.1.1 By Application
6.4.3.1.2 By Product
6.4.3.2 Japan Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.2.1 By Application
6.4.3.2.2 By Product
6.4.3.3 India Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.3.1 By Application
6.4.3.3.2 By Product
6.4.3.4 South Korea Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.4.1 By Application
6.4.3.4.2 By Product
6.4.3.5 Singapore Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.5.1 By Application
6.4.3.5.2 By Product
6.4.3.6 Malaysia Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.6.1 By Application
6.4.3.6.2 By Product
6.4.3.7 Thailand Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.6.1 By Application
6.4.3.6.2 By Product
6.4.3.8 Indonesia Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.7.1 By Application
6.4.3.7.2 By Product
6.4.3.9 Vietnam Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.8.1 By Application
6.4.3.8.2 By Product
6.4.3.10 Taiwan Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.10.1 By Application
6.4.3.10.2 By Product
6.4.3.11 Rest of Asia Pacific Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.11.1 By Application
6.4.3.11.2 By Product
6.5 Middle East and Africa Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.1 By Application
6.5.2 By Product
6.5.3 By Country
6.5.3.1 Saudi Arabia Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.1.1 By Application
6.5.3.1.2 By Product
6.5.3.2 U.A.E. Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.2.1 By Application
6.5.3.2.2 By Product
6.5.3.3 Israel Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.3.1 By Application
6.5.3.3.2 By Product
6.5.3.4 South Africa Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.4.1 By Application
6.5.3.4.2 By Product
6.5.3.5 Rest of Middle East and Africa Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.5.1 By Application
6.5.3.5.2 By Product
6.6 Central and South America Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.1 By Application
6.6.2 By Product
6.6.3 By Country
6.6.3.1 Brazil Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.1.1 By Application
6.6.3.1.2 By Product
6.6.3.2 Argentina Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.2.1 By Application
6.6.3.2.2 By Product
6.6.3.3 Chile Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.3.1 By Application
6.6.3.3.2 By Product
6.6.3.3 Rest of Central and South America Embolic Protection Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.3.1 By Application
6.6.3.3.2 By Product
7 COMPETITIVE LANDCAPE
7.1 Company Market Share Analysis
7.2 Four Quadrant Positioning Matrix
7.2.1 Market Leaders
7.2.2 Market Visionaries
7.2.3 Market Challengers
7.2.4 Niche Market Players
7.3 Vendor Landscape
7.3.1 North America
7.3.2 Europe
7.3.3 Asia Pacific
7.3.4 Rest of the World
7.4 Company Profiles
7.4.1 Boston Scientific Corp
7.4.1.1 Business Description & Financial Analysis
7.4.1.2 SWOT Analysis
7.4.1.3 Products & Services Offered
7.4.1.4 Strategic Alliances between Business Partners
7.4.2 Edward Lifesciences
7.4.2.1 Business Description & Financial Analysis
7.4.2.2 SWOT Analysis
7.4.2.3 Products & Services Offered
7.4.2.4 Strategic Alliances between Business Partners
7.4.3 Abbott Laboratories
7.4.3.1 Business Description & Financial Analysis
7.4.3.2 SWOT Analysis
7.4.3.3 Products & Services Offered
7.4.3.4 Strategic Alliances between Business Partners
7.4.4 Medtronic Plc
7.4.4.1 Business Description & Financial Analysis
7.4.4.2 SWOT Analysis
7.4.4.3 Products & Services Offered
7.4.4.4 Strategic Alliances between Business Partners
7.4.5 Cardinal Health
7.4.5.1 Business Description & Financial Analysis
7.4.5.2 SWOT Analysis
7.4.5.3 Products & Services Offered
7.4.5.4 Strategic Alliances between Business Partners
7.4.6 Claret Medical, Inc.
7.4.6.1 Business Description & Financial Analysis
7.4.6.2 SWOT Analysis
7.4.6.3 Products & Services Offered
7.4.6.4 Strategic Alliances between Business Partners
7.4.7 Innovative Cardiovascular Solutions, LLC
7.4.7.1 Business Description & Financial Analysis
7.4.7.2 SWOT Analysis
7.4.7.3 Products & Services Offered
7.4.7.4 Strategic Alliances between Business Partners
7.4.8 Transverse Medical, Inc.
7.4.8.1 Business Description & Financial Analysis
7.4.8.2 SWOT Analysis
7.4.8.3 Products & Services Offered
7.4.8.4 Strategic Alliances between Business Partners
7.4.9 Claret Medical, Inc.
7.4.9.1 Business Description & Financial Analysis
7.4.9.2 SWOT Analysis
7.4.9.3 Products & Services Offered
7.4.9.4 Strategic Alliances between Business Partners
7.4.10 Gore Medical
7.4.10.1 Business Description & Financial Analysis
7.4.10.2 SWOT Analysis
7.4.10.3 Products & Services Offered
7.4.10.4 Strategic Alliances between Business Partners
7.4.11 Other Companies
7.4.11.1 Business Description & Financial Analysis
7.4.11.2 SWOT Analysis
7.4.11.3 Products & Services Offered
7.4.11.4 Strategic Alliances between Business Partners
8 RESEARCH METHODOLOGY
8.1 Market Introduction
8.1.1 Market Definition
8.1.2 Market Scope & Segmentation
8.2 Information Procurement
8.2.1 Secondary Research
8.2.1.1 Purchased Databases
8.2.1.2 GMEs Internal Data Repository
8.2.1.3 Secondary Resources & Third Party Perspectives
8.2.1.4 Company Information Sources
8.2.2 Primary Research
8.2.2.1 Various Types of Respondents for Primary Interviews
8.2.2.2 Number of Interviews Conducted throughout the Research Process
8.2.2.3 Primary Stakeholders
8.2.2.4 Discussion Guide for Primary Participants
8.2.3 Expert Panels
8.2.3.1 Expert Panels Across 30+ Industry
8.2.4 Paid Local Experts
8.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
8.3 Market Estimation
8.3.1 Top-Down Approach
8.3.1.1 Macro-Economic Indicators Considered
8.3.1.2 Micro-Economic Indicators Considered
8.3.2 Bottom Up Approach
8.3.2.1 Company Share Analysis Approach
8.3.2.2 Estimation of Potential Product Sales
8.4 Data Triangulation
8.4.1 Data Collection
8.4.2 Time Series, Cross Sectional & Panel Data Analysis
8.4.3 Cluster Analysis
8.5 Analysis and Output
8.5.1 Inhouse AI Based Real Time Analytics Tool
8.5.2 Output From Desk & Primary Research
8.6 Research Assumptions & Limitations
8.6.1 Research Assumptions
8.6.2 Research Limitations
LIST OF TABLES
1 Global Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
2 Neurovascular Diseases Market, By Region, 2021-2029 (USD Mllion)
3 Cardiovascular Diseases Market, By Region, 2021-2029 (USD Mllion)
4 Peripheral Vascular Diseases Market, By Region, 2021-2029 (USD Mllion)
5 Global Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
6 Distal Occlusion Filters Market, By Region, 2021-2029 (USD Mllion)
7 Proximal Occlusion Filters Market, By Region, 2021-2029 (USD Mllion)
8 Distal Filters Market, By Region, 2021-2029 (USD Mllion)
9 Regional Analysis, 2021-2029 (USD Mllion)
10 North America Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
11 North America Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
12 North America Embolic Protection Devices Market, By country, 2021-2029 (USD Mllion)
13 U.S. Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
14 U.S. Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
15 Canada Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
16 Canada Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
17 Mexico Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
18 Mexico Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
19 Europe Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
20 Europe Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
21 Europe Embolic Protection Devices Market, By country, 2021-2029 (USD Mllion)
22 Germany Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
23 Germany Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
24 U.K. Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
25 U.K. Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
26 France Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
27 France Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
28 Italy Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
29 Italy Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
30 Spain Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
31 Spain Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
32 Netherlands Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
33 Netherlands Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
34 Rest Of Europe Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
35 Rest Of Europe Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
36 Asia Pacific Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
37 Asia Pacific Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
38 Asia Pacific Embolic Protection Devices Market, By country, 2021-2029 (USD Mllion)
39 China Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
40 China Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
41 Japan Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
42 Japan Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
43 India Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
44 India Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
45 South Korea Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
46 South Korea Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
47 Singapore Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
48 Singapore Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
49 Thailand Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
50 Thailand Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
51 Malaysia Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
52 Malaysia Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
53 Indonesia Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
54 Indonesia Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
55 Vietnam Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
56 Vietnam Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
57 Taiwan Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
58 Taiwan Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
59 Rest of APAC Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
60 Rest of APAC Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
61 Middle East and Africa Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
62 Middle East and Africa Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
63 Middle East and Africa Embolic Protection Devices Market, By country, 2021-2029 (USD Mllion)
64 Saudi Arabia Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
65 Saudi Arabia Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
66 UAE Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
67 UAE Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
68 Israel Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
69 Israel Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
70 South Africa Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
71 South Africa Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
72 Rest Of Middle East and Africa Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
73 Rest Of Middle East and Africa Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
74 Central and South America Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
75 Central and South America Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
76 Central and South America Embolic Protection Devices Market, By country, 2021-2029 (USD Mllion)
77 Brazil Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
78 Brazil Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
79 Chile Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
80 Chile Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
81 Argentina Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
82 Argentina Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
83 Rest Of Central and South America Embolic Protection Devices Market, By Application, 2021-2029 (USD Mllion)
84 Rest Of Central and South America Embolic Protection Devices Market, By Product, 2021-2029 (USD Mllion)
85 Boston Scientific Corp: Products & Services Offering
86 Edward Lifesciences: Products & Services Offering
87 Abbott Laboratories: Products & Services Offering
88 Medtronic Plc: Products & Services Offering
89 Cardinal Health: Products & Services Offering
90 CLARET MEDICAL, INC.: Products & Services Offering
91 Innovative Cardiovascular Solutions, LLC : Products & Services Offering
92 Transverse Medical, Inc.: Products & Services Offering
93 Claret Medical, Inc., Inc: Products & Services Offering
94 Gore Medical: Products & Services Offering
95 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Embolic Protection Devices Market Overview
2 Global Embolic Protection Devices Market Value From 2021-2029 (USD Mllion)
3 Global Embolic Protection Devices Market Share, By Application (2022)
4 Global Embolic Protection Devices Market Share, By Product (2022)
5 Global Embolic Protection Devices Market, By Region (Asia Pacific Market)
6 Technological Trends In Global Embolic Protection Devices Market
7 Four Quadrant Competitor Positioning Matrix
8 Impact Of Macro & Micro Indicators On The Market
9 Impact Of Key Drivers On The Global Embolic Protection Devices Market
10 Impact Of Challenges On The Global Embolic Protection Devices Market
11 Porter’s Five Forces Analysis
12 Global Embolic Protection Devices Market: By Application Scope Key Takeaways
13 Global Embolic Protection Devices Market, By Application Segment: Revenue Growth Analysis
14 Neurovascular Diseases Market, By Region, 2021-2029 (USD Mllion)
15 Cardiovascular Diseases Market, By Region, 2021-2029 (USD Mllion)
16 Peripheral Vascular Diseases Market, By Region, 2021-2029 (USD Mllion)
17 Global Embolic Protection Devices Market: By Product Scope Key Takeaways
18 Global Embolic Protection Devices Market, By Product Segment: Revenue Growth Analysis
19 Distal Occlusion Filters Market, By Region, 2021-2029 (USD Mllion)
20 Proximal Occlusion Filters Market, By Region, 2021-2029 (USD Mllion)
21 Distal Filters Market, By Region, 2021-2029 (USD Mllion)
22 Regional Segment: Revenue Growth Analysis
23 Global Embolic Protection Devices Market: Regional Analysis
24 North America Embolic Protection Devices Market Overview
25 North America Embolic Protection Devices Market, By Application
26 North America Embolic Protection Devices Market, By Product
27 North America Embolic Protection Devices Market, By Country
28 U.S. Embolic Protection Devices Market, By Application
29 U.S. Embolic Protection Devices Market, By Product
30 Canada Embolic Protection Devices Market, By Application
31 Canada Embolic Protection Devices Market, By Product
32 Mexico Embolic Protection Devices Market, By Application
33 Mexico Embolic Protection Devices Market, By Product
34 Four Quadrant Positioning Matrix
35 Company Market Share Analysis
36 Boston Scientific Corp: Company Snapshot
37 Boston Scientific Corp: SWOT Analysis
38 Boston Scientific Corp: Geographic Presence
39 Edward Lifesciences: Company Snapshot
40 Edward Lifesciences: SWOT Analysis
41 Edward Lifesciences: Geographic Presence
42 Abbott Laboratories: Company Snapshot
43 Abbott Laboratories: SWOT Analysis
44 Abbott Laboratories: Geographic Presence
45 Medtronic Plc: Company Snapshot
46 Medtronic Plc: Swot Analysis
47 Medtronic Plc: Geographic Presence
48 Cardinal Health: Company Snapshot
49 Cardinal Health: SWOT Analysis
50 Cardinal Health: Geographic Presence
51 Claret Medical, Inc.: Company Snapshot
52 Claret Medical, Inc.: SWOT Analysis
53 Claret Medical, Inc.: Geographic Presence
54 Innovative Cardiovascular Solutions, LLC : Company Snapshot
55 Innovative Cardiovascular Solutions, LLC : SWOT Analysis
56 Innovative Cardiovascular Solutions, LLC : Geographic Presence
57 Transverse Medical, Inc.: Company Snapshot
58 Transverse Medical, Inc.: SWOT Analysis
59 Transverse Medical, Inc.: Geographic Presence
60 Claret Medical, Inc., Inc.: Company Snapshot
61 Claret Medical, Inc., Inc.: SWOT Analysis
62 Claret Medical, Inc., Inc.: Geographic Presence
63 Gore Medical: Company Snapshot
64 Gore Medical: SWOT Analysis
65 Gore Medical: Geographic Presence
66 Other Companies: Company Snapshot
67 Other Companies: SWOT Analysis
68 Other Companies: Geographic Presence
The Global Embolic Protection Devices Market has been studied from the year 2019 till 2029. However, the CAGR provided in the report is from the year 2024 to 2029. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Embolic Protection Devices Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
